Sensei Biotherapeutics (SNSE) Peer Comparison

$25.96

$-10.21 (-28.23%)

As on 17-Jul-2026 09:30EDT

Market cap

$19 Mln

Revenue (TTM)

$-5 Mln

P/E Ratio

--

P/B Ratio

4.9

Div. Yield

0 %

Edit

	Sensei Biotherapeutics (SNSE)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Market cap ($ Mln)	19	16,504	17,747	14,622	12,501
Revenue ($ Mln)	-5	2,782	1,054	2,436	1,284
Net Profit ($ Mln)	-195.53	491.50	755.85	860.62	-325.10
Net Margin (%)	4,030.69	17.67	71.69	35.33	-25.32
RoE (%)	-204.15	110.09	--	42.98	-57.72
Price to Earnings	--	34.72	20.93	18.56	--
Price-To-Book	4.86	38.18	10.51	7.95	23.94

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Sensei Biotherapeutics (SNSE)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Operating Revenue	-4.85	2,782.29	1,054.37	2,435.92	1,283.94
Cost of Revenue	132.89	1,982.07	103.47	85.67	109.42
Gross Profit	--	760.62	588.53	2,236.43	902.26
Operating Expenses	65.86	216.81	841.45	1,378.74	1,497.13
Operating Profit (EBIT)	-198.82	583.40	109.45	971.51	-322.62
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-195.53	598.92	101.11	1,035.47	-325.10
Provision for Tax	0.00	107.42	-654.74	174.84	0.00
Profit after Tax (Net Income)	-195.53	491.50	755.85	860.62	-325.10
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Sensei Biotherapeutics (SNSE)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Shareholder's Funds	172.96	433.86	1,435.90	1,843.76	523.72
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	0.00	187.89	384.48	288.55	346.72
Current Liabilities	9.58	1,435.43	464.70	361.93	374.20
Total Liabilities	22.90	1,975.47	1,302.02	2,844.42	1,259.59

Assets ($ Mln)

	Sensei Biotherapeutics (SNSE)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Non-Current Assets	0.65	1,006.90	895.24	1,243.41	45.47
Current Assets	188.66	1,050.29	1,389.84	1,250.82	1,199.18
Total Assets	22.90	1,975.47	1,302.02	2,844.42	1,259.59
Total Debt*	0.59	120.10	449.89	165.93	347.75
Net Current Assets	179.08	-385.14	925.52	888.90	824.98

Cashflow ($ Mln)

	Sensei Biotherapeutics (SNSE)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Cash From Operating Activities	-20.45	713.22	51.77	884.27	-189.55
Cash Flow from Investing Activities	19.77	-31.14	-8.15	350.44	32.32
Cash from Financing Activities	-0.65	-860.39	34.89	-969.59	255.98
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Sensei Biotherapeutics (SNSE)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
ROCE (%)	-67.65	53.56	-30.01	32.82	-31.49
ROE (%)	-204.15	110.09	163.18	42.98	-57.72
ROA (%)	-166.73	15.64	31.68	29.32	-22.97
EBIT Margin (%)	4,030.51	21.13	5.73	31.04	-18.97
Net Margin (%)	4,030.69	17.67	71.69	35.33	-25.32
Cash Profit Margin (%)	0.03	0.00	0.00	0.00	0.00

Growth Ratios

	Sensei Biotherapeutics (SNSE)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Revenue Growth (%)	-991.73	24.67	114.85	9.23	149.04
EBIT Growth (%)	-630.59	18.70	136.39	-3.99	9.16
Net Profit Growth (%)	-628.96	17.50	378.76	42.89	-15.32
EPS Growth (%)	-2,860.65	26.84	353.27	50.42	-0.64
Book Value Growth (%)	41.49	164.02	816.12	-0.70	-42.66

Valuation Ratios

	Sensei Biotherapeutics (SNSE)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Price / Earnings	-0.64	36.06	-59.76	15.79	-45.32
Price / Book Value	0.72	38.18	10.51	7.95	23.94
Dividend Yield (%)	--	0.00	0.00	0.00	0.00
EV/EBITDA	0.30	27.00	230.43	13.21	-39.74
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Sensei Biotherapeutics (SNSE)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debt to Equity	0.00	0.00	0.27	0.00	0.65
Short term debt to equity ratio	0.00	0.00	0.05	0.00	0.00
Current Ratio	19.69	0.73	2.99	3.46	3.20
Quick Ratio	19.69	0.73	2.32	3.38	2.94
Interest Coverage	-21,724.44	--	1.62	--	-9.32

Operating Efficiency Ratios

	Sensei Biotherapeutics (SNSE)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debtors to sales (%)	0.00	15.88	21.25	13.74	14.98
Asset Turnover	-0.04	0.89	0.44	0.83	0.91
Receivable days	--	50.42	85.52	43.48	35.88
Inventory Days	--	--	1,056.70	96.17	354.23
Payable days	--	6.26	331.01	147.97	300.79
Cash Conversion Cycle	--	--	811.21	-8.32	89.33

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly